AMPH

Amphastar Pharma

• Seeking Alpha·09/30 19:41

  Amphastar: 2 Years Since My Last Hold Call, I Remain On The Sidelines

• Simply Wall St·09/29 04:33

  Amphastar Pharmaceuticals (AMPH) Rebounds On Momentum, Is The 20% Premium Already Too Rich?

• Simply Wall St·09/18 21:24

  Amphastar Pharmaceuticals (AMPH) Could Be 4% Above Fair Value After Its Q2 Beat

• Seeking Alpha·09/17 18:21

  Looming biosimilar void risks $189B in lost U.S. healthcare savings: report

• Simply Wall St·09/05 10:20

  Is Amphastar Pharmaceuticals (AMPH) Cheap After Its Recent Share Price Rebound?

• TipRanks·09/02 15:05

  Wells Fargo Sticks to Their Hold Rating for Amphastar Pharmaceuticals (AMPH)

• NASDAQ·08/31 15:10

  Zacks Industry Outlook Highlights Amphastar Pharmaceuticals, Sandoz and Viatris

• NASDAQ·08/27 17:06

  3 Generic Drug Stocks to Watch Amid Improving Industry Trends

• Benzinga·08/24 21:06

  12 Health Care Stocks Moving In Monday's After-Market Session

• TipRanks·08/21 00:19

  Amphastar Pharmaceuticals Earnings Call Balances Growth And Risk

• Dow Jones·08/18 18:10

  Amphastar Pharmaceuticals Is Maintained at Equal-Weight by Barclays

• Dow Jones·08/18 18:10

  Amphastar Pharmaceuticals Price Target Raised to $23.00/Share From $20.00 by Barclays

• TipRanks·08/18 15:15

  Amphastar price target raised to $23 from $20 at Barclays

• Simply Wall St·08/14 10:42

  Lead Independent Director Richard Prins Sold A Bunch Of Shares In Amphastar Pharmaceuticals

• NASDAQ·08/14 08:06

  New Strong Sell Stocks for August 14th